Several drugs have been approved by the food and drug administration (FDA) for patients with Alzheimer disease (Figure 1) including galantamine and Donepezil which are selective for AChE while rivastigmine and tacrine were found to inhibit both BuChE and AChE [16]. This evidence concerns the gene ACHE and Alzheimer disease.